Drtech KRX:214680KOSDAQ
디알텍 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days2
Articles tracked0since Sep 11
In Q2 2026, Drtech reported revenue of ₩37.0bn, up 10.3% year on year, and operating profit of ₩1.9bn. Drtech (디알텍) appeared in 0 Korean news articles and 2 DART filings over the past seven days.
Drtech quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩37.0bn | +10.3% | ₩1.9bn | ₩2.1bn |
| Q1 2026 | ₩31.8bn | +25.5% | −₩596m | −₩885m |
| Q4 2025 derived | ₩23.3bn | -14.6% | −₩13.0bn | −₩16.6bn |
| Q3 2025 | ₩34.0bn | +27.9% | ₩1.7bn | ₩2.8bn |
| Q2 2025 | ₩33.6bn | +27.4% | ₩922m | −₩5.9bn |
| Q1 2025 | ₩25.4bn | +46.8% | −₩3.5bn | −₩4.4bn |
| Q4 2024 derived | ₩27.3bn | +18.4% | −₩2.2bn | −₩5.1bn |
| Q3 2024 | ₩26.6bn | +15.0% | −₩2.5bn | −₩4.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Drtech top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Drtech news Korean headlines
No articles yet.